LGT Capital Partners LTD. purchased a new position in Stryker Corporation (NYSE:SYK) in the fourth quarter, Holdings Channel reports. The fund purchased 31,300 shares of the medical technology company’s stock, valued at approximately $4,846,000.

Several other large investors also recently modified their holdings of the stock. Acrospire Investment Management LLC acquired a new position in Stryker in the second quarter worth $111,000. Sit Investment Associates Inc. boosted its holdings in Stryker by 114.3% in the fourth quarter. Sit Investment Associates Inc. now owns 825 shares of the medical technology company’s stock worth $128,000 after purchasing an additional 440 shares during the period. Motco boosted its holdings in Stryker by 50.7% in the second quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 278 shares during the period. Oak Point Wealth Management acquired a new position in Stryker in the fourth quarter worth $145,000. Finally, San Francisco Sentry Investment Group CA boosted its holdings in Stryker by 47.8% in the third quarter. San Francisco Sentry Investment Group CA now owns 1,005 shares of the medical technology company’s stock worth $143,000 after purchasing an additional 325 shares during the period. Institutional investors and hedge funds own 74.90% of the company’s stock.

A number of equities analysts have commented on the stock. SunTrust Banks reaffirmed a “buy” rating and issued a $161.00 price objective on shares of Stryker in a report on Monday, October 2nd. Oppenheimer set a $156.00 price objective on shares of Stryker and gave the stock a “hold” rating in a report on Monday, October 30th. Canaccord Genuity lifted their price objective on shares of Stryker from $155.00 to $162.00 and gave the stock a “buy” rating in a report on Friday, October 27th. Zacks Investment Research downgraded shares of Stryker from a “hold” rating to a “sell” rating in a report on Monday, October 16th. Finally, Cowen set a $160.00 price objective on shares of Stryker and gave the stock a “buy” rating in a report on Friday, October 6th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $156.60.

In related news, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $155.34, for a total value of $776,700.00. Following the completion of the sale, the insider now owns 83,207 shares of the company’s stock, valued at $12,925,375.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 7.40% of the company’s stock.

Shares of Stryker Corporation (NYSE SYK) traded down $1.24 on Thursday, hitting $159.54. 1,255,000 shares of the stock traded hands, compared to its average volume of 1,228,157. Stryker Corporation has a 52 week low of $119.17 and a 52 week high of $164.20. The firm has a market capitalization of $59,460.00, a P/E ratio of 34.02, a price-to-earnings-growth ratio of 2.30 and a beta of 0.78. The company has a current ratio of 2.37, a quick ratio of 1.61 and a debt-to-equity ratio of 0.63.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, October 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.50 by $0.02. Stryker had a net margin of 14.67% and a return on equity of 24.11%. The company had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.97 billion. During the same quarter in the previous year, the company posted $1.39 earnings per share. The company’s revenue for the quarter was up 6.1% compared to the same quarter last year. equities analysts expect that Stryker Corporation will post 6.47 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Investors of record on Friday, December 29th will be issued a $0.47 dividend. The ex-dividend date is Thursday, December 28th. This represents a $1.88 annualized dividend and a yield of 1.18%. This is an increase from Stryker’s previous quarterly dividend of $0.43. Stryker’s dividend payout ratio is presently 40.09%.

TRADEMARK VIOLATION WARNING: This report was first published by Daily Political and is owned by of Daily Political. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.dailypolitical.com/2018/01/11/lgt-capital-partners-ltd-invests-4-85-million-in-stryker-corporation-syk.html.

About Stryker

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.